article · Cell Communication and Signaling
Exosomes are emerging as dynamic regulators of cellular crosstalk. Exosomal long non-coding RNAs (Exo-lncRNAs) are now recognized as key molecular mediators of diabetes mellitus. These molecules are interrelated with β-cell function, insulin resistance, inflammation, and diabetic complications. Key diabetes-related exo-lncRNAs include exo-P3134, which supports β-cell compensation, as well as exo-MALAT1 and exo-GAS5, which are regulators of insulin resistance and β-cell dysfunction. This review unravels the complex interplay between exo-lncRNAs and the hallmarks of diabetes, across disease pathogenesis and complications. It also spotlights the unprecedented potential of exo-lncRNAs as non-invasive biomarkers and next-generation therapeutic targets in precision medicine in diabetes. By combining mechanistic and translational evidence, this review offers the first integrative framework that positions exo-lncRNAs at the center of diabetes progression and opens new avenues for translational applications.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1186/s12964-026-02739-w
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
